Revised SPC: Maviret (glecaprevir and pibrentasvir) 100 mg/40 mg Film-coated Tablets

SPC has been revised to shorten treatment duration in treatment-naïve subjects with compensated cirrhosis and HCV GT3 infection, from 12 to 8 weeks based on results from study M16-135.

Source:

electronic Medicines compendium